Login / Signup
Three-year update outcomes of the first chimeric antigen receptor-T therapy for children and young adults with relapsed/refractory acute lymphoblastic leukemia.
Hideki Nakayama
Published in:
Translational pediatrics (2024)
Keyphrases
</>
acute lymphoblastic leukemia
young adults
allogeneic hematopoietic stem cell transplantation
childhood cancer
type diabetes
diffuse large b cell lymphoma
multiple myeloma
adipose tissue
insulin resistance